CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Subcutaneous Interleukin-2 Monotherapy for Metastatic Renal Cell Carcinoma in Korean Patients
Jeong Ho Kim, Ki Soo Lee, Choung-Soo Kim, Young Deuk Choi, Tae Hyo Kim
Korean J Urol Oncol. 2021;19(4):252-260.   Published online 2021 November 25    DOI: https://doi.org/10.22465/kjuo.2021.19.4.252

Excel Download

Subcutaneous Interleukin-2 Monotherapy for Metastatic Renal Cell Carcinoma in Korean Patients
The Korean Journal of Urological Oncology. 2021;19(4):252-260   Crossref logo
Link1 Link2 Link3

Outpatient treatment with subcutaneous interleukin-2, interferon alpha and fluorouracil in patients with metastatic renal cancer: an Australian experience
Internal Medicine Journal. 2005;35(1):34-38   Crossref logo
Link1 Link2

Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma
Yearbook of Oncology. 2006;2006:158-159   Crossref logo
Link1 Link2

A Phase II trial of intravenous gemcitabine and 5-fluorouracil with subcutaneous interleukin-2 and interferon-? in patients with metastatic renal cell carcinoma
Cancer. 2002;94(10):2602-2609   Crossref logo
Link1 Link2

RE: C-REACTIVE PROTEIN: A BIOMARKER OF SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH SUBCUTANEOUS INTERLEUKIN-2 BASED IMMUNOTHERAPY
Journal of Urology. 2005;174(6):2422-2423   Crossref logo
Link1 Link2 Link3

Subcutaneous Interleukin-2 and Interferon in metastatic renal cell carcinoma: Our experience
Urologia Journal. 1996;63(4):467-475   Crossref logo
Link1 Link2

Interleukin-2 and metastatic renal-cell carcinoma
The Lancet. 1992;339(8803):1224   Crossref logo
Link1 Link2

Application of the International Metastatic Renal Cell Carcinoma Database Consortium and Memorial Sloan Kettering Cancer Center Risk Models in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multi-Institutional Retrospective Study Using the Korean Metastatic Renal Cell Carcinoma Registry
Cancer Research and Treatment. 2019;51(2):758-768   Crossref logo
Link1 Link2 Link3

Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206
Yearbook of Urology. 2009;2009:90-91   Crossref logo
Link1 Link2

Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206
Yearbook of Oncology. 2009;2009:93-94   Crossref logo
Link1 Link2